Table 1.

Patient characteristics and laboratory measurements

	n (%) or median [IQR]
Patient characteristics
Age (years)	53 [37, 63]
Gender: male/female	14 (70)/6 (30)
Weight (kg)	79 [64, 85]
Height (m)	1.69 [1.65, 1.80]
28-day mortality	9 (45)
SAPS II	78 [69, 90]
Norepinephrine n (%), and dosage (mg/h) at start	17 (85), 0.90 [0.60, 1.60]
Norepinephrine n (%), and dosage (mg/h) after 12 h	12 (60), 0.65 [0.50, 1.20]
Vasopressin n (%), and dosage (IE/h) at start	7 (35) 2.0 [1.5, 2.5]
Vasopressin n (%), and dosage (IE/h) after 12 h	5 (25) 2.0 [0.5, 2.0]
Laboratory parameters before initiation of Cytosorb®
Total bilirubin (mg/dl)	14.7 [11.6, 18.6]
Conjugated bilirubin (mg/dl)	12.5 [10.0, 15.1]
Total BAs (µmol/l)	59 [44, 140]
Alanine aminotransferase (U/l)	160 [96, 271]
Aspartate aminotransferase (U/l)	180 [115, 677]
γ-Glutamyltransferase (U/l)	446 [96, 941]
Alkaline phosphatase (U/l)	368 [160, 780]

SAPS II Simplified Acute Physiology Score, BA bile acid